Prolonged clinical benefit of everolimus therapy in the management of high-grade pancreatic neuroendocrine carcinoma
Publication date:
2013
Publisher version:
Citación:
Case Reports in Oncology, 6(2), p. 441-449 (2013); doi:10.1159/000354754
Descripción física:
p. 441-449
ISSN:
Identificador local:
20131179
DOI:
Patrocinado por:
Financial support for medical editorial assistance was provided by Novartis Pharmaceuticals.
Files in this item
![Thumbnail](/dspace/bitstream/handle/10651/19967/Prolonged%20Clinical%20Benefit%20of%20Everolimus%20Therapy%20in%20the%20Management%20of%20High-Grade%20Pancreatic%20Neuroendocrine%20Carcinoma.pdf.jpg?sequence=5&isAllowed=y)